State of New Jersey Common Pension Fund D Sells 5,676 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

State of New Jersey Common Pension Fund D trimmed its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 31.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,179 shares of the medical instruments supplier's stock after selling 5,676 shares during the quarter. State of New Jersey Common Pension Fund D's holdings in ICU Medical were worth $2,219,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of ICUI. Motco acquired a new stake in shares of ICU Medical during the 1st quarter worth approximately $29,000. Innealta Capital LLC bought a new stake in shares of ICU Medical in the 2nd quarter worth $32,000. Hexagon Capital Partners LLC lifted its position in shares of ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock worth $36,000 after buying an additional 122 shares in the last quarter. Allworth Financial LP increased its holdings in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock worth $36,000 after buying an additional 100 shares during the last quarter. Finally, EntryPoint Capital LLC increased its stake in shares of ICU Medical by 731.5% during the 1st quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier's stock worth $48,000 after purchasing an additional 395 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Stock Performance

Shares of ICUI stock traded down $3.67 during trading hours on Friday, hitting $168.29. 89,615 shares of the company's stock were exchanged, compared to its average volume of 274,772. The company has a current ratio of 2.29, a quick ratio of 1.08 and a debt-to-equity ratio of 0.75. The business's 50 day simple moving average is $176.32 and its 200-day simple moving average is $142.19. ICU Medical, Inc. has a 12-month low of $82.82 and a 12-month high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The medical instruments supplier reported $1.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.88 by $0.35. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The business had revenue of $580.07 million for the quarter, compared to analyst estimates of $574.77 million. As a group, sell-side analysts expect that ICU Medical, Inc. will post 3.81 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on ICUI shares. KeyCorp boosted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They issued a "hold" rating and a $183.00 price target for the company. Raymond James raised their target price on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research note on Thursday, September 12th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Wednesday. Finally, StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a report on Tuesday. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $173.00.

Insider Buying and Selling

In other ICU Medical news, VP Daniel Woolson sold 2,502 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $163.22, for a total value of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. This represents a 16.03 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $171.84, for a total value of $2,062,080.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $17,973,261.12. This trade represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 38,502 shares of company stock valued at $6,573,496 over the last three months. Corporate insiders own 6.70% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.